Back to Newsroom

Pharnext to Attend January Investor Conferences

Paris, January 4, 2017 – Pharnext SA (FR00111911287 – ALPHA), a French biopharmaceutical company developing an advanced portfolio of products in the field of neurodegenerative diseases, announced today that senior management will be attending the following conferences taking place in January in France:

 Oddo 20th Midcap Forum on January 5-6 in Lyon Convention Center

 Invest Securities BioMed Event – 2 nd Edition – on January 26 in Salons Hoche, Paris

Click here to read the full release